Childhood chronic myeloid leukemia in accelerated phase with EVI1 positive: report of one case and review of literature

C. Zhuang, Xiuxia Chen, Pingping Wei, Liang Hui
{"title":"Childhood chronic myeloid leukemia in accelerated phase with EVI1 positive: report of one case and review of literature","authors":"C. Zhuang, Xiuxia Chen, Pingping Wei, Liang Hui","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.12.013","DOIUrl":null,"url":null,"abstract":"目的 \n提高对EVI1基因阳性的儿童慢性粒细胞白血病加速期(CML-AP)的认识。 \n \n \n方法 \n回顾性分析青岛市妇女儿童医院2019年1月收治的1例EVI1基因阳性的儿童CML-AP患者的临床资料,并复习相关文献。 \n \n \n结果 \n患儿,男性,14岁,确诊后,加用国产伊马替尼联合小剂量化疗方案,达血液学完全缓解。BCR-ABL p210定量降至4.66%,EVI1定量降至正常(0.01%)。 \n \n \n结论 \n儿童CML-AP罕见,临床特征主要为白细胞计数明显升高和巨脾。国产伊马替尼联合小剂量化疗方案对EVI1基因阳性的儿童CML-AP治疗有效,远期疗效尚需密切随访。","PeriodicalId":9505,"journal":{"name":"肿瘤研究与临床","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"肿瘤研究与临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.12.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

目的 提高对EVI1基因阳性的儿童慢性粒细胞白血病加速期(CML-AP)的认识。 方法 回顾性分析青岛市妇女儿童医院2019年1月收治的1例EVI1基因阳性的儿童CML-AP患者的临床资料,并复习相关文献。 结果 患儿,男性,14岁,确诊后,加用国产伊马替尼联合小剂量化疗方案,达血液学完全缓解。BCR-ABL p210定量降至4.66%,EVI1定量降至正常(0.01%)。 结论 儿童CML-AP罕见,临床特征主要为白细胞计数明显升高和巨脾。国产伊马替尼联合小剂量化疗方案对EVI1基因阳性的儿童CML-AP治疗有效,远期疗效尚需密切随访。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
EVI1阳性儿童慢性粒细胞白血病加速期1例报告及文献复习
Objective: To improve understanding of the accelerated phase of chronic myeloid leukemia (CML-AP) in children with EVI1 gene positivity. Method: A retrospective analysis was conducted on the clinical data of one EVI1 gene positive child CML-AP patient admitted to Qingdao Women and Children's Hospital in January 2019, and relevant literature was reviewed. The patient, male, 14 years old, was diagnosed and received a combination of domestic imatinib and low-dose chemotherapy, achieving complete hematological remission. The quantification of BCR-ABL p210 decreased to 4.66%, and the quantification of EVI1 decreased to normal (0.01%). Conclusion: CML-AP in children is rare, and its clinical features mainly include a significant increase in white blood cell count and splenomegaly. The combination of domestic imatinib and low-dose chemotherapy is effective in the treatment of CML-AP in children with EVI1 gene positivity, but the long-term efficacy still needs close follow-up.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
肿瘤研究与临床
肿瘤研究与临床 Medicine-Oncology
CiteScore
0.10
自引率
0.00%
发文量
7737
期刊介绍:
期刊最新文献
Progress of the relationship between breast cancer and thyroid diseases Analysis of cancer incidence and mortality in registration areas of Shanxi Province in 2014 Expressions of human epidermal growth factor receptor 2 in recurrent patients after radical gastrectomy and its significance Progress of molecular markers related to papillary thyroid carcinoma Significance of changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in neoadjuvant therapy for rectal cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1